We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,824 results
  1. Treatment of ankylosing spondylitis with TNFα inhibitors does not affect serum levels of tryptophan metabolites

    The imbalance between the kynurenine and serotonin pathways can have serious consequences, e.g., depression. One of the factors leading to the...

    Joanna Witoszyńska-Sobkowiak, Dorota Sikorska, ... Włodzimierz Samborski in Inflammopharmacology
    Article Open access 30 August 2023
  2. The Role of H3K27me3-Mediated Th17 Differentiation in Ankylosing Spondylitis

    Ankylosing spondylitis (AS) is a common chronic progressive inflammatory autoimmune disease. T helper 17 (Th17) cells are the major effector cells...

    Yuening Chen, Wanlin Liu, ... Hongxiao Liu in Inflammation
    Article 22 March 2024
  3. MICA and NLRP3 gene polymorphisms interact synergistically affecting the risk of ankylosing spondylitis

    Ankylosing spondylitis (AS) is an autoinflammatory disease that affects the sacroiliac joints, causing stiffness and pain in the back. MICA is a...

    Javier Fernández-Torres, Yessica Zamudio-Cuevas, ... Karina Martínez-Flores in Immunologic Research
    Article 04 September 2023
  4. DNA methylation and transcriptome signatures of the PDCD1 gene in ankylosing spondylitis

    Ankylosing spondylitis (AS) is an autoimmune-related inflammatory arthritis. The association between the DNA methylation and mRNA expression of PDCD1 ...

    Ye Wu, Yuting Chen, ... Faming Pan in Genes & Immunity
    Article 27 January 2023
  5. SPI1 Regulates the Progression of Ankylosing Spondylitis by Modulating TLR5 via NF-κB Signaling

    Ankylosing spondylitis (AS) is an autoimmune disease which associated with inflammation of the spinal joints. Enhanced osteogenic differentiation was...

    Dai Wenbo, He Yifu, Kai Li in Inflammation
    Article 06 June 2023
  6. Microorganisms in the Pathogenesis and Management of Ankylosing Spondylitis

    Ankylosing spondylitis (AS) is a chronic systemic auto-inflammatory disease that mainly affects sacroiliac joints and the axial skeleton. AS shows...
    Aigul Sharip, Zhussipbek Mukhatayev, ... Jeannette Kunz in Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases
    Chapter 2022
  7. Genetic variability of three common NK and γδ T cell receptor genes (FCγ3R, NCR3, and DNAM-1) and their role in Polish patients with rheumatoid arthritis and ankylosing spondylitis

    Various lymphocyte subpopulations, including NK cells as well as γδ T cells, have been considered an important element in the pathogenesis of...

    Sylwia Biały, Milena Iwaszko, ... Katarzyna Bogunia-Kubik in Immunologic Research
    Article Open access 07 May 2024
  8. STAT3 and SPI1, may lead to the immune system dysregulation and heterotopic ossification in ankylosing spondylitis

    Objective

    This study was aimed to identify the biomarkers for diagnosis and reveal the immune microenvironment changes in ankylosing spondylitis (AS).

    ...
    Tuo Liang, Jiarui Chen, ... Chong Liu in BMC Immunology
    Article Open access 22 January 2022
  9. Long noncoding RNA intersectin 1-2 gradually declines during adalimumab treatment, and its reduction correlates with treatment efficacy in patients with ankylosing spondylitis

    Previous studies show that long noncoding RNA intersectin 1-2 (lnc-ITSN1-2) promotes the inflammation process and serves as a potential biomarker in...

    Mingwu Li, **anjie Zhou in Inflammopharmacology
    Article Open access 18 August 2021
  10. Analysis of inflammation-related microRNA expression in patients with ankylosing spondylitis

    Ankylosing spondylitis (AS) is a complex genetic disease characterized by axial skeletal inflammation. Available scientific evidence suggests that a...

    Huiling Tan, Ruyu Ren, ... Bin Yang in Immunologic Research
    Article 06 November 2021
  11. Comparison of the antibacterial activity of Australian Terminalia spp. extracts against Klebsiella pneumoniae: a potential treatment for ankylosing spondylitis

    Traditional medicines prepared using Terminalia species have been used globally to treat inflammation and pathogenic infections. Recent studies have...

    Reece Courtney, Ian Edwin Cock in Inflammopharmacology
    Article 06 January 2022
  12. Upregulation of Unfolded Protein Response and ER Stress–Related IL-23 Production in M1 Macrophages from Ankylosing Spondylitis Patients

    The inflammatory interleukin (IL)-23/IL-17 axis plays an important role in the pathogenesis of ankylosing spondylitis (AS), but with an unknown...

    Alireza Rezaiemanesh, Mahdi Mahmoudi, ... Mohammad Hossein Nicknam in Inflammation
    Article 03 February 2022
  13. Immune-related adverse events (irAEs) in ankylosing spondylitis (AS) patients treated with interleukin (IL)-17 inhibitors: a systematic review and meta-analysis

    Background

    Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease characterized by immune system dysregulation and inflammation in...

    Hossein Azadeh, Reza Alizadeh-Navaei, ... Misagh Rajabinejad in Inflammopharmacology
    Article 21 February 2022
  14. Janus kinase inhibitors for treating active ankylosing spondylitis: a meta-analysis of randomized controlled trials

    Objective

    In this study, we aimed to assess the safety and efficacy of Janus kinase (JAK) inhibitors in patients with ankylosing spondylitis (AS).

    ...
    Y. H. Lee, G. G. Song in Zeitschrift für Rheumatologie
    Article 18 December 2020
  15. Quality of internet videos related to exercise therapy of ankylosing spondylitis from mainland China

    Objective

    The aim of this study is to assess the quality and reliability of online videos on ankylosing spondylitis (AS) exercises from the five most...

    Yan Sang, Jialing Chen, ... Hailin Jiang in Zeitschrift für Rheumatologie
    Article 01 December 2020
  16. Association of methylation level and transcript level in TRAF5 gene with ankylosing spondylitis: a case-control study

    To explore the association between methylation level and transcript level of TNF receptor-associated factor 5 (TRAF5) gene with ankylosing...

    Shanshan Xu, **ng Gao, ... Faming Pan in Genes & Immunity
    Article 21 May 2021
  17. Aberrant antigen processing and presentation: Key pathogenic factors leading to immune activation in Ankylosing spondylitis

    The strong association of HLA-B*27 with ankylosing spondylitis (AS) was first reported nearly 50 years ago. However, the mechanistic link between...

    Akihiro Nakamura, Shaghayegh Foroozan Boroojeni, Nigil Haroon in Seminars in Immunopathology
    Article 02 February 2021
  18. Spondyloarthropathies and arthritis post-infection: a historical perspective

    The spondyloarthropathies are a group of conditions characterised by spinal joint pain and have related clinical, epidemiological and genetic-related...

    W. Watson Buchanan, Colin A. Kean, ... Walter F. Kean in Inflammopharmacology
    Article 07 September 2023
  19. Circulating interleukin-23 levels in ankylosing spondylitis and their correlation with disease activity

    Objective

    To systematically investigate the relationship between circulating interleukin-23 (IL‑23) levels and ankylosing spondylitis (AS) and...

    Y. H. Lee, G. G. Song in Zeitschrift für Rheumatologie
    Article 26 April 2020
  20. Oxidative stress-mediated mitochondrial dysfunction facilitates mesenchymal stem cell senescence in ankylosing spondylitis

    Ankylosing spondylitis (AS) is a chronic inflammatory disease possessing a morbid serum microenvironment with enhanced oxidative stress. Long-term...

    Guiwen Ye, Zhongyu **e, ... Huiyong Shen in Cell Death & Disease
    Article Open access 17 September 2020
Did you find what you were looking for? Share feedback.